AUS
NZ
UK
CA
USA
IND
Health
What Challenges Lie Ahead for This Emerging AI-Powered Health Tech Innovator?
December 18, 2024 11:58 PM PST| By Team Kalkine MediaHighlights,Ainos focuses on AI-driven healthcare advancements.,VELDONA therapy progresses with human and veterinary clinical trials.,Partnerships established for manufacturing and development.,Ainos,(NASDAQ:AIMD),is a biotechnology company specializi...
Why Is Bicycle Therapeutics Facing Such Steep Declines in Revenue?
December 18, 2024 11:54 PM PST| By Team Kalkine MediaHighlights,Bicycle Therapeutics develops innovative therapeutic solutions in biopharmaceuticals.,Recent earnings report shows advancements in operational performance.,Focused on addressing unmet medical needs through proprietary technology.,Bicycle T...
Why Did PTC Therapeutics Stock Drop Midweek?
December 18, 2024 11:30 PM PST| By Team Kalkine MediaHighlights,PTC Therapeutics develops treatments for rare genetic disorders in the biotechnology sector.,Recent trading saw PTCT shares decrease to $45.46 with moderate trading volume.,Metrics include a $3.51 billion market cap and a beta of 0.63, ind...
What’s Behind the Latest Equity Grants at Quantum-Si?
December 18, 2024 11:09 PM PST| By Team Kalkine MediaHighlights,Quantum-Si drives advancements in protein sequencing for precision medicine.,Restricted stock units granted under the 2023 Inducement Plan to new employees.,Compliance maintained with Nasdaq Listing Rule 5635(c)(4) for equity awards.,The p...
Zimmer Biomet Holdings (NYSE:ZBH) and the Dilemma of Shareholder Returns
December 18, 2024 09:43 AM PST| By Team Kalkine MediaHighlights,Zimmer Biomet Holdings stock has fallen 23% in the past five years.,Despite profitability, the stock has underperformed the market.,Total shareholder return of 23% over the last five years.,Zimmer Biomet Holdings Inc.has faced significant...
Cencora (NYSE:COR) Shares Climb, But Earnings Growth Lags Behind
December 18, 2024 09:37 AM PST| By Team Kalkine MediaHighlights,Cencora has experienced a 166% increase in stock value over five years.,Shareholder returns surpass earnings growth, with an annualized TSR of 23%.,Despite recent setbacks, Cencora remains a strong performer in the long term.,Cencora Inc....
Analyzing the Recent Price Movement of Avanos Medical, Inc. (NYSE:AVNS)
December 18, 2024 09:36 AM PST| By Team Kalkine MediaHighlights,Avanos Medical saw significant price changes recently.,The stock is trading around US$17.02, raising questions about its true worth.,Despite price drops, Avanos maintains a positive growth.,Avanos Medical Inc. a key player in the healthcar...
Why Is Fulcrum Therapeutics Struggling to Maintain Market Confidence?
December 18, 2024 01:12 AM PST| By Team Kalkine MediaHighlights,NASDAQ FULC opened trading at $4.54 on Friday.,Shares recorded a 12-month low of $2.86 and a high of $13.70.,The market capitalization is approximately $244.88 million.,Fulcrum Therapeutics operates in the biotechnology sector, focusing on...
Why Is IGM Biosciences Struggling Despite Its Promising Biotech Advances?
December 18, 2024 01:02 AM PST| By Team Kalkine MediaHighlights,IGM Biosciences listed on NASDAQ with ticker IGMS.,Market capitalization is approximately $445 million.,Stock price has shown significant variability over the past year.,IGM Biosciences,(NASDAQ:IGMS),operates within the biotechnology secto...
Why Is BullFrog AI's New CFO Appointment Raising Concerns in Biotech Circles?
December 18, 2024 12:58 AM PST| By Team Kalkine MediaHighlights,BullFrog AI Holdings names Josh Blacher as new CFO,Blacher has over 20 years in life sciences finance,Focus on enhancing financial operations and strategic initiatives,BullFrog AI Holdings,(NASDAQ:BFRG),operates within the biotechnology se...
Which Biotech Stock Faces a Steeper Challenge This Year?
December 18, 2024 12:38 AM PST| By Team Kalkine MediaHighlights,Aclaris Therapeutics holds 98.3% institutional share ownership.,Gross revenue reported by Aclaris is $27.08 million.,Theratechnologies exhibits a lower Price/Sales ratio than Aclaris.,Within the biotechnology sector, companies like Aclaris...
Why Is Alumis Facing a Critical Turning Point This December?
December 18, 2024 12:26 AM PST| By Team Kalkine MediaHighlights,Alumis operates in the biotechnology sector focusing on innovative medical treatments.,Lock-up period ending December 25th allows insiders to trade their shares.,Public offering in June raised $210 million through issuance of over 13 milli...
Why Is CorVel's Stock Movement Raising Eyebrows This Week?
December 17, 2024 11:22 PM PST| By Team Kalkine MediaHighlights,CorVel operates within the healthcare and insurance services sector.,Provides risk management and claims solutions to employers and insurance entities.,Focuses on enhancing claims management through technology-driven solutions.,CorVel,(NAS...
Is Schrödinger’s Latest Stock Grant a Game-Changer for New Hires?
December 17, 2024 11:19 PM PST| By Team Kalkine MediaHighlights,Schrödinger granted RSUs under its 2021 Equity Incentive Plan.,Six new employees received shares as part of their compensation.,The awards align with Nasdaq Listing Rule 5635(c)(4).,Schrödinger, Inc.,(NASDAQ:SDGR),operates in the biotechno...
Enzo Biochem (NYSE:ENZ) Quarterly Loss and Institutional Adjustments
December 17, 2024 08:10 AM PST| By Team Kalkine MediaHighlights,Enzo Biochem faces challenges with negative margins and fluctuating stock price.,Institutional involvement is significant, with several firms adjusting their stakes.,The company recently released quarterly results, revealing a loss in earn...
Is Cash Burn a Warning Sign for This Stock’s Future?
December 17, 2024 03:02 AM PST| By Team Kalkine MediaHighlights,American Well operates in the digital health technology sector,Focuses on cash reserves and annual spending rate,Cash burn impacts its growth funding timeline,American Well,(NYSE:AMWL),operates within the digital health technology sector,...
Centene (NYSE:CNC) Attracts Hedge Fund Attention
December 16, 2024 08:00 AM PST| By Team Kalkine MediaHighlights,Centene receives an upgrade from UBS Group.,Hedge funds and institutional investors show increased interest in Centene.,Company maintains strong financial metrics with a low debt-to-equity ratio.,Centene Corp.a major player in the U.S. hea...
Is This Phase 2b Trial A Game-Changer for Lung Health Treatments?
December 16, 2024 12:06 AM PST| By Team Kalkine MediaHighlights,Positive outcomes reported for deupirfenidone in treating idiopathic pulmonary fibrosis.,Study met primary and secondary objectives, demonstrating effectiveness over placebo in mitigating lung function decline.,A significant portion of par...
Is Sutro Biopharma Set to Dominate Over Novavax in the Stock Arena?
December 15, 2024 11:07 PM PST| By Team Kalkine MediaHighlights,Sutro Biopharma,(NASDAQ:STRO),and Novavax operate within the biotechnology sector,Sutro Biopharma is recognized for its innovative therapeutic approaches,Novavax focuses on vaccine development and has an established market presence,The bio...
Scholar Rock's Equity Grants: A Step Toward Biopharma Innovation?
December 15, 2024 10:58 PM PST| By Team Kalkine MediaHighlights,Scholar Rock,(NASDAQ:SRRK),specializes in biopharmaceutical solutions targeting protein growth factors.,The company announced inducement equity awards for new employees, including stock options and restricted stock units.,Scholar Rock focu...
